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ABSTRACT
A recent investigation revealed an apparent cholesteryl ester hydrolysis in 
low density lipoproteins (LDL) upon incubation with reconstituted high density 
lipoproteins (r-HDL). Since r-HDL contains apolipoprotein A-l (apoA-I) and 
egg phosphatidylcholine (egg-PC), this work attempts to reveal if the apoA-I, 
the egg-PC in vesicle form, or the r-HDL is the agent responsible for this 
hydrolysis* The results of this study show that there is no increase in free 
cholesterol in LDL upon incubation with either apoA-l or egg-PC vesicles* 
Thus, it is concluded that the intact r-HDL upon incubation with LDL causes 
the change in LDL composition.
ACKNOWLEDGMENTS
I extend a sincere thank-you to Dr. Ana Jonas and the Jonas' group f 
their help and encouragement throughout the past year.
Also, 1 would especially like to thank my parents for their continued 
support and encouragement throughout my four years at the University of 
Illinois.
LIST OF ABBREVIATIONS
LDL
HDL
VLDL
ApoB
ACAT
LCAT
LCP
CETP
PLTP
DPPC
Bgg-PC
CEME
DMPC
r-HDL
ApoA-I
Low density Lipoproteins 
High density Lipoproteins 
Very low density Lipoproteins 
ApoLipoproteir. B
Acyl-CoA:cholesterol acyl transferase 
Lecithin cholesterol acyl transferase 
Lipoprotein complexing proteoglycan 
Cholesteryl ester transfer protein 
Phospholipid transfer protein 
Dipalmitoyl phosphatidylcholine 
Egg Phosphatidylcholine
Cholesterol ester~phospholipid microemulsions 
Dimyristoyl phosphatidylcholine 
Reconstituted high density lipoproteins 
Apolipoprotein A-I
TABLE OF CONTENTS
I. INTRODUCTION
Page
1
II. EXPERIMENTAL 12
A. Materials. •
B. Instruments
C. Methods....
11 .
... 13
L .
1 ... 13J  .
A T ___t__ C  t nt . k L A  _  _ « T / _______ _nr* Uaairlofl. • * ... 144 •
c
Incubations ot lul with ApoA-l/cgg ru vesictc».••••
... 15
J  .
c ... 150 . 
7. Free and Total Cholesterol Determination.......... ... 15
III. RESULTS AND DISCUSSION
16
REFERENCES
22
TABLES AND FIGURES
25
LIST OF TABLES AND FICURES
Table 1 Percent Composition of LDL
Table 2 Comparison of Total Cholesterol Assays
Table 3 Composition of LDL After Incubation with 
ApoA-I ac 37°C
Table 4 Composition of LDL After Incubation with 
Egg-PC Vesicles at 37QC
Figure 1 Plot of LDL/ApoA-I Incubation
Figure 2 Craph of LDL/Egg-PC Vesicle Incubation
INTRODUCTION
The plasma lipoproteins are the major source for transport of insoluble 
lipids in an aqueous environment. They consist of a neutral lipid core 
containing primarily triglycerides and cholesteryl esters and an outer shell 
of phospiiol ipid, apol i poproteins, and some cholesterol. The various 
lipoproteins can be distinguished based on the differing proportions of these 
constituents. These complexes can be divided into four basic categories. 
Chylomicrons transport dietary triglycerides and cholesterol while very low 
density lipoproteins (VLDL) transport triglycerides which have been 
synthesized in the liver. Low density lipoproteins (LDL) and high density 
lipoproteins (HDL) are the major carriers of endogenous cholesterol. These 
lipoproteins are readily isolated by ultracentrifugation at the appropriate 
density.
Low density lipoproteins are a major topic of research since a positive 
correlation between them and atherosclerosis has been determined. These 
lipoproteins of density 1.019*1.063 g/ml contain approximately 29% protein, 
21% phospholipid, 9% free cholesterol, 4% triglyceride, and 40% cholesteryl 
esters (1) in a quasi-spherical particle with a diameter of 200-250& and a 
molecular weight of 2-3.5 x 10^ million. However, Shen et ai. (1) has 
determined that low density lipoproteins are heterogeneous even within the 
individual. They have separated LDL into at least three subgroups which 
differ in particle size, hydrated density, and chemical composition. These 
subspecies were shown to correlate differently between men and women.
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Like other lipoproteins, LDL contains the triglycerides and cholesteryl 
esters in the core of the molecule. The cholesteryl ester/triglyceride ratio 
determines wheth r the core is in a smectic-like liquid crystalline or liquid 
state. The phospholipid and protein form a coat around the core with the 
protein, apolipoprotein B (apoB) extended 5-10A from the polar heads of the 
phospholipid. Twenty percent of the phospholipid appears to be in a 
restricted conformation due to its interaction with apoB. Lund-Katz and 
Phillips (2) have shown that 65% of the free cholesterol content of LDL is 
located with the phospholipid in the outer layer while the rest is associated 
with the core. These two cholesterol locations are in continual exchange and 
are described as one physiological pool. Lund-Katz and Phillips (2) have also 
shown that the intramolecular exchange as well as the intermolecular exchange 
of cholesterol in LDL is much slower than that in HDL. They attribute this to 
a greater acyl chain saturation of phosphatidylcholine, and higher 
sphingomyelin/phosphatidylcholine and free cholesterol/phosphoiipid ratios in 
LDL. In gener/1 , they feel that the phospholipid and cholesterol are more 
tightly packed in the LDL.
The protein in LDL is 95-98% apoB. This represents approximately 
17-32 mg/100 mg of LDL. ApoB is a huge, insoluble protein which is 
susceptible to degradation and oxidative cleavage, with a molecular weight of 
512,000 daLtons. Glutamic acid is the amino terminal residue and a blocked 
serine is the carboxyterminal residue. ApoB is also a glycoprotein with 
carbohydrates representing 5% of its total mass. The main carbohydrates 
present include glucose, galactose, mannose, fucose, glucosamine, and sialic 
acids which are all N~linked to glucosamine through asparagine residues (3).
There are six pairs of intramolecular disulfide bonds and two free half­
cystine residues in 250,000 g of protein* Pertaining to these cystine 
residues is a recent discovery by Huang, Lee, and Singh (4) who invest ^ated 
the presence ol thiol ester linked palmitate and stearate in the apoB 
structure which are labile to mild alkaline conditions.
ApoB is the feature that the LDL receptor recognizes as postulated by 
Brown and Goldstein (5,6), thus revealing the importance of studying its 
primary structure. ApoB-48 of intestinal origin and apoB-100 of hepatic 
origin are the major forms of apoB with B-48 found mainly in chylomicrons and 
B-100 found in VLDL, IDL, and LDL. There exists a proteolytic cleavage within 
B-100, the major apoprotein in LDL, in plasma which reveals two fragments,
B-74 and B-26. Cardin et al. (7) incubated LDL with kallikrein which degraded 
B-100 into four fragments in the same order as that of natural proteolytic 
cleavage. This involved the B-100 separating into two fragments, B-26 and 
B-74 and subsequent cleavage of B-74 into B-44 and B-30. B-26 was found at
the amino terminus while B-74 was located at the carboxy terminus with B-44 
contained within the sequence and B-30 found at the very end. Ail of these 
fragments have been found to some degree in LDL but have been identified 
merely as artifacts.
Also, the sequence of B-48 was located along with B-26 at the amino 
terminus of B-100. A recent investigation revealed that the mRNA encoding 
B-48 contains an in-frame UAA stop codon produced from a C to U change in the 
CAA codon in B-100 mKNA (8). The termination codon ends the protein with an 
isoleucine residue* However, a methionine residue is the actual carboxy
4terminus which is possibly due to the removal of the carboxy terminal residue 
by carboxypeptidase A, an enzyme which removes nonpolar residues from the 
carboxy terminus of proteins. This result is important since it essentially 
states that B-100 and B-48 are the products of a single gene even though the 
mechanism involved is unknown.
The complete cDNA and amino acid sequence of human B-100 has been 
determined by two methods including sequencing tryptic peptides and partial 
cDNA clones (9*10). These studies revealed a 4563-amino acid protein 
comprised of a 27-amino acid signal peptide and a mature protein of 4536 
residues. Other characteristics of B-100 revealed included a high 
hydrophobicity of 0.916 kcal/residue with a large number of these residues 
located at the carboxy end and the proportions of secondary structure 
including 42% a-helix, 21% 8-sheet, 20% random structure, and 16% 0 turns.
Dot matrix analysis revealed many long (> 70 residues) internal repeats and 
many more shorter repeats. Yang et al. (10) suggests from these results that 
the sequence of B-100 is derived from internal duplications. Further 
experimentation with trypsin revealed five hypothetical domains since trypsin- 
accessible and -inaccessible peptides were found to be nonrandom on the LDL. 
Finally, 20 possible N-glycosylation sites with 13 being glycosylated and 
4 unglycosylated were located along with a potential LDL receptor binding 
domain.
Formation of LDL is through a process involving VLDL, a triglyceride-rich 
lipoprotein containing apoB as well as other apoproteins. This particle is 
released into the plasma from the liver and is transported to adipose
stissue* An enzyme, lipoprotein lipase, removes triglycerides from the VLDL 
causing all proteins other than apoB to leave also* The choiesteryl ester 
content ot this particle increases mainly due to the effect of lecithin 
cholesterol acyl transferase (LCAT), an enzyme which removes a fatty acid from 
the sn-2 position of lecithin and transfers it to cholesterol. HDL is the 
main source of the choiesteryl esters since it appears to be the substrate for 
LCAT, and a lipid transfer protein will exchange choiesteryl esters and 
triglycerides between LDL and HDL. Once these processes take place to a 
sufficient level the VLDL becomes LDL (5). Although this is the accepted 
pathway, Rudel, Parks, Johnson, and Babiak (11) have discovered that a certain 
amount of LDL may be directly secreted into the circulation. From 25% to 75% 
of LDL is from VLDL conversion while the rest is due to this secretion 
depending l .» the particular laboratory animal*
LDL catabolism takes place through receptor-mediated endocytosis* LDL 
binds to a receptor which is located in a coated pit containing the protein 
clathrin. The LDL and receptor are internalized and form a coated vesicle* 
Eventually the coated vesicle is delivered to a lysosome as the receptor is 
recycled to the cell surface* In the lysosome, the coat breaks down and the 
fatty acids are cut from the choiesteryl esters* The free cholesterol is used 
in synthesizing membranes and hormones* If the cholesterol concentration 
increases three control mechanisms take over. First, HMG CoA reductase, an 
enzyme in cholesterol biosynthesis is inhibited. Second, acyl-CoA cholesterol 
acyltransferase (ACAT) esterifies the cholesterol for storage. Finally, the 
synthesis of LDL receptors is stopped. A small number or the absence of LDL
receptors and a defect in the receptor mechanism contribute to an increase in 
LDL in the circulation and an increased risk of atherosclerosis*
Certain characteristics of the LDL currently being studied may have a 
direct effect on the interaction with receptors* Among the properties which 
affect the binding of LDL to its receptor or proteoglycans, constituents of 
the arterial wall, include the molecular weight of LDL, its surface charge, 
the state of the core cholesteryl esters, the conformation of apoB, and the 
presence of other apoproteins (11), Came jo et al* (12) magnified some of 
these effects by studying complexes formed between LDL and a lipoprotein 
complexing proteoglycan (LCP) which is extracted from the human arterial 
intimal media* This LDL/LCP complex may be important in the formation of 
atherosclerotic plaque* LDL which contains more cholesterol, less sialic 
acid, and has a higher isoelectric point seems to promote the formation of the 
LDL/LCP complex* Also, a very important result by Camejo et al* (12) showed 
that HDL inhibits this complex formation* This apparently is associated with 
the apoprotein present in HDL and presents a possible way in which HDL may 
deter atherogenesis*
Many modifications of LDL are used to analyze its physiological 
properties* Specifically these modifications are used to measure the effects 
of cholesteryl ester exchange and transfer proteins (CETP), LCAT, and 
phospholipid transfer proteins (PLTP)* The main effect of CETP and LCAT on 
LDL is the incorporation of cholesteryl esters into its neutral lipid core* 
LCAT acts on HDL to esterify the cholesterol while the CETP is responsible for 
the bidirectional exchange of cholesteryl esters and triglycerides between LDL
7and HDL. Zechner et al. (13) recently investigated plasma incubations with 
both LCAT and CETP or just CETP alone. The CETP incubation alone resulted in 
an increase in triglycerides and a decrease in cholesteryl esters in the LDL 
core with no structural changes in the LDL itself while the incubation with 
LCAT decreased the polar lipids, phospholipids and cholesterol in LDL and 
reduced the LDL particle size without changing its properties. They feel this 
reduction in particle size due to LCAT may have a negative effect on LDL 
binding to its receptor.
Various studies have been done to develop a technique to study 
cholesteryl ester exchange. Krieger et al. (1A) extracted the cholesteryl 
ester core of LDL and incorporated two fluorescent probes PNCA oleate and 
dioleyl fluorescein. These probes were used to monitor LDL uptake by its 
receptor and to identify receptor-deficient cells. Incubation of plasma or 
LDL plus lipoprotein-free plasma with cholesteryl ester-rich microemulsions 
leads to a transfer of cholesteryl esters into the LDL core as monitored by 
fluorescent probes (13). This transfer is mediated by a cholesteryl ester 
transfer protein in the plasma and has no deleterious effects on the LDL 
structure or properties. A similar process to create a cholesteryl ester 
probe involved incubation of plasma with density > 1.006 at 37°C with 
[^Cjcholesteryl ester containing liposomes (16). Again the radiolabeled 
cholesteryl esters were found in the core of the LDL with no structural or 
functional changes in LDL occurring. LDL with radiolabeled cholesteryl esters 
from this procedure was incubated with HDL to monitor the kinetics of 
transfer. The result agreed with a previous equilibrium transfer model.
8The ability to monitor the phospholipid exchange protein activity with 
LDL is possible with the use of phospholipid vesicles* Jackson, Cardin, 
Barnhart, and Johnson (17) isolated bovine liver phosphatidylcholine exchange 
protein and prepared an incubation of this protein, LDL, and di [ ^ C|palmitoy! 
phosphatidylcholine (DPPC) vesicles. The result included a transfer of the 
radiolabeled DPPC into the LDL depending on the temperature. At 42°C there 
was complete exchange of the phospholipid. An increase in the total 
phospholipid of LDL along with an increased lipid rigidity was discovered with 
fluorescence polarization studies. Another experiment showed conversion of 
LDL particle size with incubation of plasma (d > 1.2 g/ml) and 
phosphatidylcholine (PC) vesicles (18). Upon ultracentrifugation to isolate 
the LDL, the size change was no longer observed when incubated with PC 
vesicles. This proves that a protein factor in the plasma must mediate this 
process.
Similar incubations of isolated LDL and PC vesicles or cholesterol ester- 
phospholipid microemulsions (CEME) have produced aggregation of the LDL with 
the particles (19,20). Hunter, Shahrokh, Forte, and Nichols (19) noticed 
turbidity in the LDL/PC vesicle incubation along with an extreme increase in 
the phospholipid/protein ratio. They also discovered that upon tryptic 
digest, the LDL aggregation did not occur showing a connection with apoB. The 
incubations of LDL and CEME produced particles with intermediate density and 
electrophoretic mobility to those of LDL or CEME alone; hence, leading to the 
conclusion of LDL/CEME aggregation. Also, this experiment revealed that the
9addition of apoA-I, the major protein in HDL, inhibited the fusion of CEME and 
LDL. A possible conclusion to these two experiments as outlined by Parks, 
Martin, Johnson, and Rudel (20) states that apoB and apoA-I interactions may 
be responsible for LDL particle integrity.
Modifications of apoB are also important in determining structural and 
functional properties of LDL in addition to those of the protein. When 
carboxamidomethylated, tryptic digests of apoB were incubated with dimyristoyl 
phosphatidylcholine (DMPC) liposomes, lipid-peptide complexes were formed 
(21). After isolation of these complexes by ultracentrifugation, they were 
shown to be thermally stable and more rigid in structure than native LDL.
The a-helices and 6-pleated sheets underwent extreme changes with an increase 
in the a-helices and a decrease in the 0-pLeated sheets. Also, this lipid- 
peptide complex did not bind to the LDL receptor.
Finally, chemical modifications on lipoprotein B and apolipoprotein B 
were used to analyze the structure of this protein. Singh and Lee (22) 
revealed several interesting features about apolipoprotein B. First of ail, 
they found that upon storage of lipoprotein B the secondary structure of the 
protein changed even though preventive measures for peroxidation and 
degradation were taken. Second, apoB in the presence of 6M guanidine•HCl 
caused the disappearance of the a-helical structure and an increase in the 
number of 8~sheets with 6M urea restoring some of the helical structure and 
aqueous buffer restoring the structure to its normal state. Third, 
carboxymethylated and reduced-carboxymethylated apoB showed no changes in 
secondary structure. The final observation showed no change in the structure
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of apoB with a pH variance from 2.7 to 9.0. Their major conclusions from 
these results state that apoB is less stable to pH changes in the presence of 
lipids, that disulfide bonds are insignificant on the conformation of apoB and 
that the a-helical changes due to delipidation and denaturation on 
lipoprotein B are reversible.
A more recent investigation of lipid transfer activity involving 
lipoproteins contains the background information for the work in this paper. 
The investigation examined the incubation of reconstituted high density 
lipoprotein discs (r-HDL) containing egg-PC or DPPC with apoA-I and 
cholesterol with low density lipoproteins (LDL) (23). These incubations took 
place in the presence and absence of LCAT and phospholipid transfer protein 
(PLTP). The compositional and particle sixes of the r-HDL were determined. 
However, with more relevance to this work, the compositional changes of LDL 
were determined. A spontaneous transfer of phospholipids from r-HDL into LDL 
was noted with a half-time from 5.8 to 6.9 hours. This reaction was further 
facilitated with the presence of PLTP increasing the rate of transfer four­
fold. When LCAT was added to this incubation the composition of LDL returned 
to normal with a decrease in the phospholipid and free cholesterol and an 
increase in the cholesteryl ester content.
During the above investigation a few slow reactions surfaced. One of 
these reactions seemed to be a deesterification et the cholesteryl esters 
within the LDL. Since this compositional change was not observed in the LDL 
control, the r-HDL must be relevant to the process. This work attempts to
determine the agent responsible for this reaction—r-HDL, phospholipid, or 
apoA-I. LDL was incubated with egg-PC vesicles and apoA-I, separately. 
Analyzing the composition of LDL after these incubations would determine if 
the phospholipid or apoA-I contained within the r-HDL is the plausible agent 
or whether the reconstituted particle itself is.
EXPER!MENTAL
A, Materials
Plasma used for the LDL and apo*-l preparations was generously given by 
the Champaign County Blood Bank. ApoA-I was isolated by the method of 
Edelstein et al. (24). The dialysis tubing used in the LDL preparation was 
Spectrapor 4 with a molecular weight cut-off of 12,000-14,000 obtained trom 
American Scientific Products, Division of American Hospital Supply 
Corporation, McCraw Park, 1L. The reagent used in the Lowry protein assay, 
Phenol Reagent Solution, 2N was obtained from Fisher Scientific Company, 
Orangeburg, NY. Bovine serum albumin, cholesterol oxidase, horseradish 
peroxidase, cholesterol, cholesterol oleate, and egg phosphatidylcholine 
(egg-PC) were obtained from Sigma Chemical Company, St. Louis, MO. 
P-hydroxyphenylacetic acid was obtained from Aldrich Chemical Company, 
Incorporated, Milwaukee, WI, while the cholesterol esterase used in the 
enzymatic total cholesterol assay came from Calbiochem, Behring Diagnostics, 
LaJolla, CA. A High Performance Total Cholesterol Assay was obtained from 
Boehringer Mannheim, Indianapolis, IN.
B. Instruments
A Beckman Ultracentrifuge L8-70 with a Ti 55.2 rotor was used for LDL 
preparation. Absorbance values were read on a Beckman Model 35 
Spectrophotometer. For the free and total enzymatic cholesterol assays a 
Perkin-Elmer MPF-66 Fluorescence Spectrophotometer was used. Preparation of
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phospholipid vesicles by sonication was performed with a Heat Systems 
Ultrasonic Processor.
C. Methods
1. LDL Preparation
LDL from human plasma was isolated by ultracentrifugation by 
flotation at the appropriate densities (25). Plasma was adjusted with NaCl to 
a density of 1.019 g/ml and spun for 24 hours at 10 C and 50,000 rpm. After 
the spin, the top portion containing mainly VLDL, LDL, and chylomicrons was 
discarded. The bottom portion was adjusted to a density of 1.063 g/ml with 
NaCl and was spun again under the same conditions. The LDL was then isolated 
from the top portion of the tube. A final spin at 1*063 g/ml was then used to 
wash the LDL. Following these steps, the LDL was dialyzed against buffer 
composed of 10 mM Tris HCl, 150 mM NaCl, 1 mM NaN^ and 0.01X EDTA at pH 8.0, 
and stored under ^  at 4°C.
2. Bgg-PC Vesicle Preparation
A measured amount of egg-PC, equal to 0.400 ml, was dried under 
Nj. Then 5 mi of buffer previously described was added to make a 
concentration of 10 mg/ml. This concentration of egg-PC was then sonicated 
five times for three minutes with a one to two minute interval between the 
sonications.
3. ApoA-I Preparation
ApoA-I was prepared by the Edelstein et al. (24) method. The first 
step involved isolating HDL from plasma. An appropriate amount of NaCl was 
added to the plasma to give a density of 1.063 g/ml and was centrifuged using
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a Ti 55.2 rotor at 15°C and 50,000 rpm for 24 hours for separation. The top 
layer was removed and discarded. Another spin with added NaBr took place at a 
density of 1.21 g/ml to finally isolate the HDL. The HDL was then dialyz^ in 
Spectrapor 4 tubing against 10 mM Tris, EDTA/Azide (No salt) in a four liter 
flask with five buffer volumes for nine hours. The next step involved 
delipidation. HDL was slowly added to polypropylene bottles containing cold 
ethanol .‘diethylether l! 3, v/v and was stored overnight at 0°C. It was then 
spun in a centrifuge at 8-10,000 rpm at 5°C for 30 min. Then three ether 
washes were spun under the same conditions. Next the protein sample was 
dissolved in fresh 3 H Guanidine Tris buffer pH 8.2 and applied to a 
Sephacryl S-200 column. Finally, the pooled fractions containing apoA-I were 
dialyzed against five volumes of 0•01X EDTA tor 6-8 hours.
4. Incubations of LDL with ApoA-I or Egg-PC Vesicles
The LDL was heat inactivated at 55-60°C for one hour prior to the 
incubations. These incubations were carried out under N2 for differing time 
intervals in a shaking water bath at 37°C. The incubations with apoA-I 
contained 0.5 mg of apoA-I protein to 0.5 mg of LDL phospholipid in a total 
volume of 0.640 ml and were incubated for 0, 2, 6, and 18 hours. The egg-PC 
vesicle incubations were carried out for 0 and 16 hours with different ratios 
of LDL/egg-PC. These included 2.0 mg of LDL protein to 0.5, 1.0, 2.0, and 
4.0 mg of egg-PC in a total volume of 1.122 ml. Both of the above experiments 
contained controls of LDL incubated at the same time intervals.
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5. Protein Determination
LDL protein concentrations were determined by the Lowry et ai. (26) 
method as modified by Markweil et al. (27). Bovine serum albumin was used as 
the standard for the procedure.
6. Phosphate Determination
The phosphate concentration in the incubations was determined using 
the Chen et al. (28) method. A standard curve using an inorganic phosphate 
solution was constructed allowing the phosphate values of the incubations to 
be calculated.
7. Free and Total Cholesterol Determination
Initially, an enzymatic assay for free and total cholesterol 
developed by Heider and Boyett (29) and modified by Gamble, Vaughan, Kerth, 
and Avigan (30) was used. This involved preparation of a reagent containi n8 
phosphate buffer, cholesterol oxidase, horseradish peroxidase, and 
P-hydroxyphenylacetic acid with an addition of cholesterol esterase for the 
total cholesterol assay only. The standards used were free cholesterol and 
cholesterol oleate for the free and total cholesterol assays, respectively. 
The samples and standards plus the added reagent we^e incuLated at 37°C with 
the incubation time for the free cholesterol assay being 30 minutes and that 
for the total cholesterol assay 60 minutes. Fluorescence measurements were 
then made within two hours of incubation with an excitation wavelength of 
325 nm and an emission wavelength of 415 nm. A total cholesterol assay from 
Boehringer Mannheim was used to compare the results with the fluorometric 
assay above.
RESULTS AND DISCUSSION
A* Evaluation of Total Cholesterol Assay
The total cholesterol assay used in eval Kiting the incubation mixtures 
was an enzymatic assay developed by Heider and Boyett (29) and modified by 
Gamble9 Vaughan, Kerth, and Avigan (30). As previously described this assay 
involved preparing a reagent containing phosphate buffer, cholesterol oxidase, 
horseradish peroxidase, cholesterol esterase, and p-hydroxyphenylacetic 
acid. The sequence of events in this reaction mixture involved, first of all, 
the cholesterol esterase hydrolyzing the cholesteryl ester bond. The free 
cholesterol would chen release peroxide (t^C^) and choles-4-en-3-onl upon 
reaction with the enzyme cholesterol oxidase. The final step involved the 
production of a fluorescent product due to the effect of horseradish 
peroxidase on peroxide and p-hydroxyphenylacetic acid. The fluorescence was 
then easily measured using an excitation wavelength of 325 nm and an emission 
wavelength of 415 nm.
When evaluating the percent composition of LDL through chemical assays, 
the values for the cholesteryl esters were found to differ significantly from 
the accepted values. Table 1 lists the percent composition for LDL protein, 
phospholipid, cholesterol, and cholesteryl esters including the accepted 
values by Shen et al. (1) and my own. All of the values vary to a certain 
degree. There are possibly two main reasons for this. First, the difference 
in values could be due to experimental error in my technique. Second, LDL is 
known to be heterogeneous in composition in the population as well as the
16
17
individual* Since the LDL was usually isolated from plasma belonging to one 
individual, it is not a representative pool* The accepted percent composition 
of cholesteryl esters in LDL is approximately 40% by weight. The results of 
my assays ranged from 20.4-24.1%. This is very significant difference since 
it has been shown that cholesteryl esters are the major lipid in LDL.
Along with the total cholesterol assay, an assay measuring free 
cholesterol using the same reagent minus the cholesterol esterase was used.
The results from the assay seemed accurate. This revealed that a possible 
cause for the difference in cholesteryl ester composition was the cholesterol 
esterase. However, in the analysis the standard curve using cholesterol 
oleate as the standard was a linear, reproducible curve. This may suggest 
that the enzyme itself was not the problem but perhaps it was the 
accessibility of the enzyme to the cholesteryl esters located in the core of 
the LDL. The assay did call for a solution of sodium cholateJTriton X-lOOs 
absolute alcohol (1:1:2), but this may not be effective in breaking up the LDL 
particle and revealing its core constituents.
A total cholesterol kit from Boehringer Mannheim which is a colorimetric 
assay was used to compare its values with those of the fluorometric assay.
Table 2 shows that there is a significant increase in the total cholesterol 
concentration using the kit proving that the fluorometric assay is not 
accurate. However, time did not permit the experiments to be repeated using 
the kit to analyze the cholesteryl ester content, so the cholesterol 
compositional analysis is based on the fluorometric assay for free cholesterol 
only since it is reproducible and reliable.
B. Compositional Analysis of LDL Incubated with ApoA-l
An incubation of LDL containing 0.5 mg of phospholipid and 0.5 mg of 
apoA-I was carried out at 37°C for different time periods including 0, 2, 6, 
and 18 hours. LDL alone was also incubated at 37°C for the same time periods 
as a control. The reaction mixtures were analyzed for protein, phospholipid, 
and cholesterol concentrations to see if there was any change in the 
composition of the LDL in this incubation. The Lowry protein determination as 
shown in Table 3 revealed that the protein concentration within the LDL 
control and within the LDL/apoA-I incubation remained constant at 
approximately 0.962 mg/ml and 1.87 mg/ml, respectively. These values are 
different since the apoA-I adds more protein to the incubation. The 
phospholipid concentration remained the same for all eight incubations at an 
approximate value of 0.773 mg/ml. Most importantly the free cholesterol 
values remained constant in the LDL control with increasing incubation times 
as well as in the LDL/apoA-I incubations. In fact, the values for the 
separate incubations did not vary si*nificantly with an average concentration 
being 0.334 mg/ml which is shown graphically in Figure 1. Therefore, the 
composition of LDL is not changing upon incubation with the apoA-I.
C. Compositional Analysis of LDL Incubated with Egg-PC Vesicles
A similar incubation containing LDL and egg-PC vesicles was also done. 
However, for these incubations varying amounts of the egg-PC vesicles were 
incubated with LDL for the same time period (16 hr) to determine whether a 
compositional change would occur in LDL in this reaction and to find the
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proper ratio of LDL/egg-PC vesicles. In the incubations 2 mg of LDL protein 
to 0.5, 1.0, 2.0, and 4.0 mg of egg-PC vesicles were incubated for 0 and 
16 hours at 37°C. LDL incubated alone for 0 and 16 hours was also included as 
a control. The results shown in Table 4 included a slight increase in the 
protein content since PC will contribute slightly to the protein 
determination. The cholesterol concentration remained the same at 
approximately 0.985 mg/ml within the LDL control and the incubations of LDL 
And egg-PC vesicles together. Figure 2 shows a much easier presentation of 
the unchanging cholesterol content. This indicates that the incubations 
between LDL and egg-PC vesicles also do not cause compositional changes in the 
LDL particle.
D. Concluding Remarks
Clearly the results from the above incubations show that neither apoA-I 
nor the addition of egg-PC vesicles to LDL caused a change in the LDL 
composition. However, this conclusion is based solely on the free cholesterol 
concentration and not on the cholesteryl ester concentration due to the 
unreliability of the total cholesterol assay. This leads to an accurate but 
rather incomplete compositional analysis. The ideal situation would be to 
repeat the incubations and use the Boehringer Mannheim total cholesterol kit 
to analyze the cholesteryl ester concentration.
Since neither the apoA-I nor the egg-PC vesicles caused the LDL 
composition to change, it must be that LDL only changes in composition upon 
incubation with the intact r-HDL particle. The apparent cholesteryl ester
hydrolysis seen by Jonas et ai» (23) in the LDL incubated with r-HDL must 
depend on the interaction between LDL and the intact r-HDL.
A possible mechanism for this cholesteryl ester hydrolysis may lie within 
the apoB in the LDL particle itself with the r-HDL possibly acting as a 
catalyst. As was described previously apoB is a huge, insoluble protein of 
which little is known except that it contains the recognition site for the LDL 
receptor. ApoB was shown to have a protease activity that produced at least 
four fragments that have been found within the LDL. Perhaps one of these 
cluaved fragments contains an apparent cholesterol esterase activity. The 
active site for esterases has been shown to exhibit the amino acid sequence of 
glycine-variable amino acid-active serine-variable amino acid-glycine (Cly-X- 
Ser-X-Cly) as was located in LCAT (31). The complete cDNA and amino acid 
sequence of apoB-100 deduced by Chen et ai. (9) however does not show this 
sequence. This still dees not rule out a possible esterase activity.
Also found within the apoB structure by Huang, L e e , and lingh (4) is the 
presence of labile thiol ester linked palmitale and stearate. This could be 
important to this work since Juahiainen and Dolphin (32) have proposed a 
mechanism for forming cholesteryl ester from cholesterol and lecithin by LCAT 
that involves a thiol ester bond as an intermediate. Their mechanism involves 
first the transfer of the sn-2 fatty acid of lecithin to the serine in the 
active site of LCAT forming lysolecithin. Next, the fatty acid is transferred 
to a cysteine from the serine forming a thiol ester bond. Finally, the fatty
20
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acid in the thiol ester bond is transferred to cholesterol forming a 
cholesteryl ester. Perhaps a thiol ester bond in apoB is an intermediate in 
the hydrolysis of cholesteryl esters.
This cholesteryl ester hydrolysis in LDL is clearly important since LDL 
with different compositions have been isolated and correlated positively and 
negatively with atherosclerosis. Therefore, future experiments are necessary 
to reveal the mechanism of this spontaneous hydrolysis. Two possible 
experiments include tryptic digest and chemical modifications of apoB on the 
LDL and subsequent incubation with r-HDL.
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TABLE 1. Percent Composition Of LDL
Protein Phospholipid Cholesterol Cholesteryl Ester
Accepted (1) 29% 21% 9% 40%
it
LOL 34.0% 27.8% 18.5% 20.4%
*
LDL 29.3% 29.6% 16.9% 24.1%
The sum of the mass of the above components was taken as 100% in each case to 
calculate the percent composition.
This LDL represents the compositional analysis that was done in this work 
using the fluorometric assay for total cholesterol.
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TABLE 2, Comparison Of Total Cholesterol Assays
Total Cholesterol 
(mg/ml)
Fluorometric Assay Boehringer Mannheim Kit
2.05 4.33
i r f r
1.99 4.22
it if
it
LDL control used in egg-PC experiment which was incubated at 37°C for 0 and 
16 hours, respectively.
it ir
The same LDL as above stored at -16.8°C.
TABLE 3. Composition Of LDL After Incubation 
With ApoA-I At 37“C
Incubation
Components
Incubation 
Time (hrs)
Protein 
(mg/mi)
Cholestero 
(mg/ml)
LDL 0 0.954 0.548
LDL 2 0.950 0.526
LDL 6 0.966 0.503
LDL 18 0.980 0.516
LDL ♦ ApoA-I 0 1.92 0.493
LDL ♦ ApoA-I 2 1.84 0.569
LDL ♦ ApoA-I 6 1.87 0.549
LDL ♦ ApoA-I 18 1.86 0.566
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TABLE A. Composition Of LDL After Incubation 
With Egg-PC Vesicles At 37°C
Incubation Incubation Protein Cholesterol
Components__________Time (hrs)__________ (mg/ml) _______ (mg/ml)
LDL 0 1.14 1.01
LDL 16 1.17 0.807
LDL ♦ 0.5 mg Egg-PC 0 1.15 0.873
LDL ♦ 0.5 mg Egg-PC 16 1.18 0.970
LDL ♦ 1.0 mg Egg-PC 0 1.20 0.981
LDL ♦ 1.0 mg Egg-PC 16 1.22 0.884
LDL ♦ 2.0 mg Egg-PC 0 1.24 1.00
LDL ♦ 2.0 mg Egg-PC 16 1.29 0.966
LDL ♦ 4.0 mg Egg-PC 0 1.36 1.16
LDL ♦ 4.0 mg Egg-PC 16 1.35 1.20
FIGURE LECENDS
Figure
Figure
Composition changes, as a function of time, of LDL incubated with 
(filled symbols) and without (open symbols) apoA-I. The cholesterol 
and protein (OA) values are normalized to 0.807 mg/ml of 
phospholipid since the phospholipid concentration remained constant 
throughout the incubations. These incubations took place at 37°C 
with 0.5 mg of LDL phospholipid and 0.5 mg of apoA-I protein.
Changes in cholesterol concentration upon incubation with various 
amounts of egg-PC vesicles. Incubations containing 2.0 mg of LDL 
protein and either 0, 0.5, 1.0, 2.0, or 4.0 mg of egg-PC took place 
at 37°C for 0 hours (plain bars) or 16 hours (slashed bars). These 
cholesterol values are normalized to 1.36 mg/ml of protein.
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